Autocrine Transforming Growth Factor β Stimulation of Extracellular Matrix Production by Fibroblasts from Fibrotic Human Gingiva

David Tipton, Mustafa Kh Dabbous

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

HEREDITARY GINGIVAL FIBROMATOSIS (HGF) is a fibrotic enlargement of the gingiva. HGF gingiva contains large amounts of collagen and other extracellular matrix (ECM) molecules. In vitro, HGF fibroblasts produce greater amounts of the ECM components fibronectin (FN) and type 1 collagen than normal human gingival (GN) fibroblasts. Transforming growth factor β(TGF β) is a cytokine important in regulating tissue repair and regeneration after injury, and stimulating fibroblast proliferation and the production of FN and collagens. The objective of this study was to determine whether HGF fibroblasts produce TGF β and, with the use of neutralizing antibodies to TGF β isoforms, if their increased expression of FN and type 1 collagen is under autocrine TGF β control. The HGF strains produced greater amounts of TGF β1 and TGF β2 (P ≤ 0.003) as well as FN (P ≤ 0.04) and type I collagen (P ≤ 0.03) (measured by specific ELISA) than the GN strains. Treatment of HGF fibroblasts with anti-TGF β1, β2, or β3, as well as a combination of all 3 antibodies, decreased their FN production by up to 60% (P ≤ 0.04), and was able to decrease FN production by HGF fibroblasts to the levels of the GN fibroblasts. When used alone, the neutralizing antibodies decreased type I collagen production by the HGF fibroblasts by up to 40% (P = 0.014), and treatment with all 3 antibodies caused decreases of up to 55% (P = 0.0005). The results suggest that autocrine stimulation by the increased amounts of TGF β isoforms made by HGF fibroblasts contributes to their increased production of FN and type 1 collagen.

Original languageEnglish (US)
Pages (from-to)609-619
Number of pages11
JournalJournal of periodontology
Volume69
Issue number6
DOIs
StatePublished - Jan 1 1998

Fingerprint

Gingiva
Transforming Growth Factors
Extracellular Matrix
Fibroblasts
Fibronectins
Collagen Type I
Neutralizing Antibodies
Gingival Fibromatosis
Protein Isoforms
Collagen
Fibromatosis, Gingival, Type 1
Antibodies
Regeneration
Enzyme-Linked Immunosorbent Assay
Cytokines
Wounds and Injuries
Therapeutics

All Science Journal Classification (ASJC) codes

  • Periodontics

Cite this

Autocrine Transforming Growth Factor β Stimulation of Extracellular Matrix Production by Fibroblasts from Fibrotic Human Gingiva. / Tipton, David; Dabbous, Mustafa Kh.

In: Journal of periodontology, Vol. 69, No. 6, 01.01.1998, p. 609-619.

Research output: Contribution to journalArticle

@article{8e5ca88abf1245f9a5eac540e7456e89,
title = "Autocrine Transforming Growth Factor β Stimulation of Extracellular Matrix Production by Fibroblasts from Fibrotic Human Gingiva",
abstract = "HEREDITARY GINGIVAL FIBROMATOSIS (HGF) is a fibrotic enlargement of the gingiva. HGF gingiva contains large amounts of collagen and other extracellular matrix (ECM) molecules. In vitro, HGF fibroblasts produce greater amounts of the ECM components fibronectin (FN) and type 1 collagen than normal human gingival (GN) fibroblasts. Transforming growth factor β(TGF β) is a cytokine important in regulating tissue repair and regeneration after injury, and stimulating fibroblast proliferation and the production of FN and collagens. The objective of this study was to determine whether HGF fibroblasts produce TGF β and, with the use of neutralizing antibodies to TGF β isoforms, if their increased expression of FN and type 1 collagen is under autocrine TGF β control. The HGF strains produced greater amounts of TGF β1 and TGF β2 (P ≤ 0.003) as well as FN (P ≤ 0.04) and type I collagen (P ≤ 0.03) (measured by specific ELISA) than the GN strains. Treatment of HGF fibroblasts with anti-TGF β1, β2, or β3, as well as a combination of all 3 antibodies, decreased their FN production by up to 60{\%} (P ≤ 0.04), and was able to decrease FN production by HGF fibroblasts to the levels of the GN fibroblasts. When used alone, the neutralizing antibodies decreased type I collagen production by the HGF fibroblasts by up to 40{\%} (P = 0.014), and treatment with all 3 antibodies caused decreases of up to 55{\%} (P = 0.0005). The results suggest that autocrine stimulation by the increased amounts of TGF β isoforms made by HGF fibroblasts contributes to their increased production of FN and type 1 collagen.",
author = "David Tipton and Dabbous, {Mustafa Kh}",
year = "1998",
month = "1",
day = "1",
doi = "10.1902/jop.1998.69.6.609",
language = "English (US)",
volume = "69",
pages = "609--619",
journal = "Journal of Periodontology",
issn = "0022-3492",
publisher = "American Academy of Periodontology",
number = "6",

}

TY - JOUR

T1 - Autocrine Transforming Growth Factor β Stimulation of Extracellular Matrix Production by Fibroblasts from Fibrotic Human Gingiva

AU - Tipton, David

AU - Dabbous, Mustafa Kh

PY - 1998/1/1

Y1 - 1998/1/1

N2 - HEREDITARY GINGIVAL FIBROMATOSIS (HGF) is a fibrotic enlargement of the gingiva. HGF gingiva contains large amounts of collagen and other extracellular matrix (ECM) molecules. In vitro, HGF fibroblasts produce greater amounts of the ECM components fibronectin (FN) and type 1 collagen than normal human gingival (GN) fibroblasts. Transforming growth factor β(TGF β) is a cytokine important in regulating tissue repair and regeneration after injury, and stimulating fibroblast proliferation and the production of FN and collagens. The objective of this study was to determine whether HGF fibroblasts produce TGF β and, with the use of neutralizing antibodies to TGF β isoforms, if their increased expression of FN and type 1 collagen is under autocrine TGF β control. The HGF strains produced greater amounts of TGF β1 and TGF β2 (P ≤ 0.003) as well as FN (P ≤ 0.04) and type I collagen (P ≤ 0.03) (measured by specific ELISA) than the GN strains. Treatment of HGF fibroblasts with anti-TGF β1, β2, or β3, as well as a combination of all 3 antibodies, decreased their FN production by up to 60% (P ≤ 0.04), and was able to decrease FN production by HGF fibroblasts to the levels of the GN fibroblasts. When used alone, the neutralizing antibodies decreased type I collagen production by the HGF fibroblasts by up to 40% (P = 0.014), and treatment with all 3 antibodies caused decreases of up to 55% (P = 0.0005). The results suggest that autocrine stimulation by the increased amounts of TGF β isoforms made by HGF fibroblasts contributes to their increased production of FN and type 1 collagen.

AB - HEREDITARY GINGIVAL FIBROMATOSIS (HGF) is a fibrotic enlargement of the gingiva. HGF gingiva contains large amounts of collagen and other extracellular matrix (ECM) molecules. In vitro, HGF fibroblasts produce greater amounts of the ECM components fibronectin (FN) and type 1 collagen than normal human gingival (GN) fibroblasts. Transforming growth factor β(TGF β) is a cytokine important in regulating tissue repair and regeneration after injury, and stimulating fibroblast proliferation and the production of FN and collagens. The objective of this study was to determine whether HGF fibroblasts produce TGF β and, with the use of neutralizing antibodies to TGF β isoforms, if their increased expression of FN and type 1 collagen is under autocrine TGF β control. The HGF strains produced greater amounts of TGF β1 and TGF β2 (P ≤ 0.003) as well as FN (P ≤ 0.04) and type I collagen (P ≤ 0.03) (measured by specific ELISA) than the GN strains. Treatment of HGF fibroblasts with anti-TGF β1, β2, or β3, as well as a combination of all 3 antibodies, decreased their FN production by up to 60% (P ≤ 0.04), and was able to decrease FN production by HGF fibroblasts to the levels of the GN fibroblasts. When used alone, the neutralizing antibodies decreased type I collagen production by the HGF fibroblasts by up to 40% (P = 0.014), and treatment with all 3 antibodies caused decreases of up to 55% (P = 0.0005). The results suggest that autocrine stimulation by the increased amounts of TGF β isoforms made by HGF fibroblasts contributes to their increased production of FN and type 1 collagen.

UR - http://www.scopus.com/inward/record.url?scp=0032088397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032088397&partnerID=8YFLogxK

U2 - 10.1902/jop.1998.69.6.609

DO - 10.1902/jop.1998.69.6.609

M3 - Article

VL - 69

SP - 609

EP - 619

JO - Journal of Periodontology

JF - Journal of Periodontology

SN - 0022-3492

IS - 6

ER -